Jun 28, 2010 by Xconomy .comOrexigen Drug Shows Potential as "Two-Fer" Against Obesity and DiabetesOrexigen's latest drug aims at treating both diabetes and obesity.
Jun 28, 2010 by Xconomy .comFuture Biotech Winners Will Help Nurses Clean Up Less (Stuff)Reduction of nausea is a key metric for cancer drugs, as the need for patient clean-up directly impacts nurse efficiency.
Jun 24, 2010 by Xconomy .comBorders Joins E-Reader Wars With Device, Apps, and a Free Cup of JoeThe battle is heating up with a new, lower price point.
Jun 24, 2010 by Xconomy .comAmylin Cuts 60 JobsThe pharmaceutical company says research is still a priority.
Jun 22, 2010 by Xconomy .comSeattle Genetics' Dark Horse Drug CandidateIt's approaching the homestretch.
Jun 22, 2010 by Xconomy .comJohn Glaser, Boston's Top Hospital Geek, Talks About Obama's Health IT Plan and Getting Booted from Catholic SchoolAn interview with John Glaser and a look at the health IT landscape in the U.S.
Jun 22, 2010 by Xconomy .comNuance Acquires ShapeWriter, Ramps Up Pressure on Seattle Startup SwypeThe company is on the prowl.
Jun 22, 2010 by Xconomy .comRegulus Therapeutics Forms $750M MicroRNA Deal With SanofiThe company has found its second big ally from Big Pharma.
Jun 21, 2010 by Xconomy .comSF and Silicon Valley: Drop the Incrementalism and Invest in True InnovationThe cradle of the American tech boom needs to focus on innovation again.
Jun 21, 2010 by Xconomy .comYou Can Go Home Again: Five Themes to Watch in the Boston Innovation SceneA quick tour of Boston's innovation community and culture.
Jun 21, 2010 by Xconomy .comStanford Biodesign, a Hothouse for Medical Devices, Shares its Secret Sauce for InventionHow do you measure an innovation's worth? By the real patients it helps.
Jun 21, 2010 by Xconomy .comCuris Misses Mark in Drug Trial; Genzyme Elects Board; GTC Cuts Jobs; and More Boston-Area Life Sciences NewsThese companies made news last week.
Jun 18, 2010 by Xconomy .comHow Seattle Startups Could Lead the World: Five Technology Themes to WatchWhich areas of technology and business innovation is Seattle poised to really own over the next few years?
Jun 18, 2010 by Xconomy .comSan Diego's Neurocrine Biosciences Scores Second Big Deal in Two DaysTwo big deals in two days for Neurocrine.
Jun 18, 2010 by Xconomy .comMotricity Completes IPO, Settles for $50 MillionThe wireless technologies company hits the Nasdaq.
Jun 17, 2010 by Xconomy .comTwo Ways to Spark More Life Science Innovation, and One Way IT Can Avoid Harming MedicineScience and information technology should drive the advance of medicine -- not get in its way.
Jun 17, 2010 by Xconomy .comBoatracs Completes Spinout From AirIQBoatracs is now an independent and privately held company, after completing a spinout from AirIQ.
Jun 17, 2010 by Xconomy .comOncothyreon’s Cancer Vaccine Back in the Saddle as Merck KGaA Re-Starts Clinical TrialsThe German-based Merck got clearance from the FDA and local ethics review boards to resume two of three large pivotal trials.
Jun 17, 2010 by Xconomy .comOwn a Volt, Get a Jolt With Free Chargers From GM and the FedsThe money to cover the 4,400 freebie 240-volt chargers comes from federal stimulus dollars.
